AC Immune (ACIU) Other Operating Expenses (2014 - 2026)

AC Immune (ACIU) has reported Other Operating Expenses for 12 consecutive years, with $14047.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 1362.94% year-over-year to $14047.1; the TTM figure through Mar 2026 stood at $139203.4 (up 69.48% YoY), while the FY2025 annual figure was $113376.1, down 30.06% from the prior year.
• Other Operating Expenses slipped to $14047.1 in Q1 2026 per ACIU's latest filing, from $91335.4 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $497009.0 in Q1 2022 and bottomed at -$1112.3 in Q1 2025.
• Historically, Other Operating Expenses has averaged $209386.3 across 5 years, with a median of $153131.0 in 2025.
• Annual changes were most pronounced in 2025 — Other Operating Expenses slumped 101.43% — and 2026, when it soared 1362.94%.
• AC Immune's Other Operating Expenses stood at $414170.7 in 2022, then fell by 3.37% to $400210.8 in 2023, then sank by 96.01% to $15981.3 in 2024, then surged by 471.51% to $91335.4 in 2025, then plunged by 84.62% to $14047.1 in 2026.
• Business Quant data shows ACIU's Other Operating Expenses at $14047.1 in Q1 2026, $91335.4 in Q4 2025, and $33820.9 in Q2 2025.